Exodus Point Capital Management, LP Spruce Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 386,702 shares of SPRB stock, worth $208,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
386,702
Previous 224,833
72.0%
Holding current value
$208,819
Previous $177,000
12.99%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SPRB
# of Institutions
42Shares Held
16.9MCall Options Held
26.9KPut Options Held
59.3K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.59 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.56 Million0.18% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.41 Million0.04% of portfolio
-
Abingworth LLP London, X01.79MShares$967,9590.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.37MShares$738,7180.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $12.7M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...